Our top pick for
This article contains links to products or services from one or more of our advertisers or partners. We may receive a commission when you click or make a purchase using our site. Learn more about how we make money.
Progenity, Inc is a biotechnology business based in the US. Progenity shares (PROG) are listed on the NASDAQ and all prices are listed in US Dollars. Progenity employs 702 staff and has a trailing 12-month revenue of around USD$80.5 million.
|Latest market close||USD$4.39|
|52-week range||USD$3.64 - USD$15.92|
|50-day moving average||USD$6.2103|
|200-day moving average||USD$8.2994|
|Wall St. target price||USD$11.6|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.9895|
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2020-11-25)||12.28%|
|1 month (2020-11-06)||-10.04%|
|3 months (2020-09-04)||-50.67%|
|6 months (2020-06-02)||N/A|
|1 year (2019-12-02)||N/A|
|2 years (2018-12-02)||N/A|
|3 years (2017-12-02)||N/A|
|5 years (2015-12-02)||N/A|
|Revenue TTM||USD$80.5 million|
|Gross profit TTM||USD$43.5 million|
|Return on assets TTM||-111.71%|
|Return on equity TTM||0%|
|Market capitalisation||USD$183.7 million|
TTM: trailing 12 months
There are currently 281,824 Progenity shares held short by investors – that's known as Progenity's "short interest". This figure is 44.3% down from 506,385 last month.
There are a few different ways that this level of interest in shorting Progenity shares can be evaluated.
Progenity's "short interest ratio" (SIR) is the quantity of Progenity shares currently shorted divided by the average quantity of Progenity shares traded daily (recently around 145270.10309278). Progenity's SIR currently stands at 1.94. In other words for every 100,000 Progenity shares traded daily on the market, roughly 1940 shares are currently held short.
However Progenity's short interest can also be evaluated against the total number of Progenity shares, or, against the total number of tradable Progenity shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Progenity's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Progenity shares in existence, roughly 0 shares are currently held short) or 0.0147% of the tradable shares (for every 100,000 tradable Progenity shares, roughly 15 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Progenity.
Find out more about how you can short Progenity stock.
We're not expecting Progenity to pay a dividend over the next 12 months.
Progenity, Inc., a biotechnology company, provides complex molecular and specialized testing services to physicians, clinicians, and their patients in the United States. It offers testing services for common hereditary disorders, cystic fibrosis, spinal muscular atrophy, fragile X syndrome, and Jewish genetic diseases; pan-ethnic carrier screening services; non-invasive prenatal, miscarriage, and pharmacogenetic testing services; and ovarian assessment reports for women. The company also provides pediatric testing services. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November, 2013. The company was incorporated in 2012 and is based in San Diego, California with a laboratory in Ann Arbor, Michigan. It has a bill payment location in Detroit, Michigan.
Steps to owning and managing HTZ, with 24-hour and historical pricing before you buy.
Steps to owning and managing HELE, with 24-hour and historical pricing before you buy.
Steps to owning and managing HE, with 24-hour and historical pricing before you buy.
Steps to owning and managing GKOS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EYEN, with 24-hour and historical pricing before you buy.
Steps to owning and managing EXAS, with 24-hour and historical pricing before you buy.
Steps to owning and managing EVFM, with 24-hour and historical pricing before you buy.
Steps to owning and managing MRAM, with 24-hour and historical pricing before you buy.
Steps to owning and managing EQNR, with 24-hour and historical pricing before you buy.
Steps to owning and managing SOLO, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.